⌘K

07:38:36·169d

SECFiling

Silence Therapeutics Plc filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

SLN· Silence Therapeutics Plc

Health Care

Original source

Companies

SLN
Silence Therapeutics Plc
Health Care

Recent analyst ratings

Feb 11UpdateGoldman$6.00
Dec 2UpdateBMO Capital Markets-
Sep 3UpdateJefferies$40.00
Jan 31UpdateBMO Capital Markets$67.00
May 8UpdateMorgan Stanley$20.00
Dec 9UpdateMorgan Stanley$18.00

Related

SEC49d
SEC Form S-8 filed by Silence Therapeutics Plc
SEC50d
SEC Form 10-K filed by Silence Therapeutics Plc
SEC50d
Silence Therapeutics Plc filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits
PR50d
Silence Therapeutics Highlights Recent Business Achievements and Reports Fourth Quarter and Full Year 2025 Financial Results
INSIDER70d
SEC Form 4 filed by Large owner Griffiths Richard Ian
INSIDER107d
SEC Form 4 filed by Director Ede-Golightly James
INSIDER107d
SEC Form 4 filed by EVP and Chief R&D Officer Romano Steven J.
INSIDER107d
SEC Form 4 filed by Director Mcinerney Timothy